Treatment of acute leukemia.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001215:Asparaginase / Q000627:therapeutic use; D001792:Blood Platelets; D001803:Blood Transfusion; D001854:Bone Marrow Cells; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D007938:Leukemia / Q000601:surgery / Q000628:therapy*; D015122:Mercaptopurine / Q000627:therapeutic use; D008670:Metals / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011379:Prognosis; D011868:Radioisotopes; D011878:Radiotherapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013256:Steroids / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D005493:Folic Acid Antagonists; D008670:Metals; D011868:Radioisotopes; D013256:Steroids; D003561:Cytarabine; D014750:Vincristine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D001215:Asparaginase; D008727:Methotrexate